Viavi Solutions Inc. filings document operating results, material events, governance actions and capital-structure matters for a Nasdaq-listed technology company. Its Form 8-K disclosures include quarterly financial results, material definitive agreements, restructuring-related exit and disposal cost disclosures, and amendments to governing documents.
VIAVI regulatory records also cover senior convertible note transactions, exchanges of prior convertible notes, proxy and governance disclosures, shareholder voting matters, director elections, officer exculpation provisions, common stock registration details and related risk, ownership and corporate-control information.
VIAVI Solutions (VIAV) reported a director equity award on a Form 4. On 11/13/2025, the reporting person received 14,369 restricted stock units (RSUs) at a price of $0, representing the right to receive the same number of shares of common stock.
The RSUs vest on the earlier of the one-year anniversary of the grant or the next Annual Meeting of Stockholders. The filing notes that RSUs have no expiration date. Following the transaction, the reporting person held 14,369 derivative securities directly, each underlying one share of common stock.
VIAVI Solutions (VIAV) director reported a grant of 14,369 restricted stock units (RSUs) on 11/13/2025, according to a Form 4 filing. The units vest on the earlier of the one-year anniversary of the grant or the next Annual Meeting of Stockholders. Following the transaction, 14,369 derivative securities were beneficially owned, with ownership reported as direct.
Viavi Solutions (VIAV) director reported an equity award of 14,369 restricted stock units (RSUs) on 11/13/2025. Each RSU is tied to one share of common stock.
The RSUs vest on the earlier of the one-year anniversary of the grant or the next Annual Meeting of Stockholders. The filing notes there are no expiration dates on RSUs.
Following the reported transaction, the director’s beneficially owned derivative securities total 14,369, held directly.
Viavi Solutions (VIAV) filed a Form 4 reporting a director’s grant of 14,369 restricted stock units (RSUs) on 11/13/2025 at a price of $0. Following the grant, the director beneficially owns 14,369 shares directly.
The RSUs vest on the earlier of the one-year anniversary of the grant or the next Annual Meeting of Stockholders. The RSUs have no expiration date.
Viavi Solutions (VIAV) disclosed a Form 4 showing a company director received 14,369 restricted stock units (RSUs) on November 13, 2025 at a price of $0.
The RSUs will vest on the earlier of the one-year anniversary of the grant or the next Annual Meeting of Stockholders, and RSUs have no expiration date. Following the transaction, 14,369 derivative securities are beneficially owned, reported as direct ownership. Each RSU represents a right to receive one share of common stock upon vesting.
Viavi Solutions (VIAV) reported an insider equity award. A director received 14,369 restricted stock units (RSUs) on 11/13/2025 at a stated price of $0. The RSUs are scheduled to vest on the earlier of the one-year anniversary of grant or the next Annual Meeting of Stockholders. Following the transaction, the reporting person beneficially owned 14,369 derivative securities, held directly. RSUs have no expiration date.
Viavi Solutions (VIAV) reported an insider equity award on Form 4. A director acquired 14,369 restricted stock units (RSUs) on 11/13/2025 at a reported price of $0.
The RSUs cover 14,369 shares of common stock and will vest on the earlier of the one-year anniversary of the grant or the next Annual Meeting of Stockholders. The filing notes there are no expiration dates on RSUs. The position is reported as direct ownership.
Viavi Solutions (VIAV) disclosed a director equity grant on Form 4. On 11/13/2025, the reporting person received 14,369 restricted stock units (transaction code A) at $0. The RSUs vest on the earlier of the one-year anniversary of the grant or the next Annual Meeting of Stockholders, and RSUs carry no expiration. After the transaction, 14,369 derivative securities were beneficially owned directly.
Viavi Solutions (VIAV) insider activity: A company director reported two open-market sales of common stock on 11/10/2025. The transactions included 23,529 shares sold at a weighted average price of $18.22 and 97,938 shares sold at a weighted average price of $18.17. Following these sales, the reporting person directly beneficially owned 27,213 shares. The filing notes that trades were executed in multiple transactions within the stated price ranges, and full trade details are available upon request.
Viavi Solutions (VIAV) reported an insider equity change by a director. On November 7, 2025, restricted stock units vested and converted into 23,529 shares of common stock at $0 per share (transaction code M). Following the settlement, the director directly holds 142,497 shares.
The RSUs convert one-for-one into common stock and vested 100% on November 7, 2025; the reported RSU balance from this grant is now 0. The filing does not show any share sales.